Homocysteine and cardiovascular disease in diabetes mellitus.
about
Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementationIntimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.Methylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitusAtorvastatin attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells via inhibiting NADPH oxidase-related oxidative stress-triggered p38MAPK signaling.Homocysteine causes cerebrovascular leakage in mice.Late cardiovascular consequences of gestational diabetes mellitus.Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempolHomocysteine downregulates gene expression of heme oxygenase-1 in hepatocytes.Carotid intimal-medial thickness is not increased in women with previous gestational diabetes mellitusHyperhomocysteinemia and B-vitamin deficiencies in infants and children.Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury.MTHFR (Ala 222 Val) polymorphism and AMI in patients with type II diabetes mellitus.Measuring subclinical atherosclerosis: is homocysteine relevant?Homocysteine and Its Relationship to Asymptomatic Carotid Stenosis in a Chinese Community Population.Does the MTHFR C677T gene polymorphism indicate cardiovascular disease risk in type 2 diabetes mellitus patients?Cobalamin status in children.Functional aspects of cytidine-guanosine dinucleotides and their locations in genes.Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin.Effects of folic acid supplementation on serum homocysteine levels, lipid profiles, and vascular parameters in post-menopausal Korean women with type 2 diabetes mellitusImpaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome.Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation.Homocysteine inhibits adipogenesis in 3T3-L1 preadipocytes.Effects of three and eight weeks oral administration of bis(maltolato)oxovanadium(IV) on plasma homocysteine and cysteine levels in streptozotocin-induced diabetic rats.Cardiovascular Protective Effects of Salvianic Acid A on db/db Mice with Elevated Homocysteine Level.Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes.Steroids, sex hormone-binding globulin, homocysteine, selected hormones and markers of lipid and carbohydrate metabolism in patients with severe hypothyroidism and their changes following thyroid hormone supplementation.Correlates of total homocysteine plasma concentration in type 2 diabetes.Heavy alcohol intake, homocysteine and Type 2 diabetes.Association of serum total homocysteine with the extent of ischemic heart disease in a Mediterranean cohort.Cavernosal dysfunction in a rabbit model of hyperhomocysteinaemia.Fractions of total plasma homocysteine in patients with ischemic stroke before the age of 55 years.Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.Menopause modulates homocysteine levels in diabetic and non-diabetic women.Effect of folic acid in women with and without insulin resistance who have hyperhomocysteinemic polycystic ovary syndrome.Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.Homocysteine-induced endothelin-1 release is dependent on hyperglycaemia and reactive oxygen species production in bovine aortic endothelial cells.Higher homocysteine and lower betaine increase the risk of microangiopathy in patients with diabetes mellitus carrying the GG genotype of PEMT G774C.A novel echocardiographic method for the detection of subclinical atherosclerosis in newly diagnosed, untreated type 2 diabetes.Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes.
P2860
Q24791545-37B7E1BC-58AC-4688-9A08-2D8FF4D0BDEAQ24796491-4ED813D9-E023-4AA6-A504-F87E4A90D238Q28274776-13F423D4-737B-4434-8C8D-240A5F7AAE60Q33555656-4EF9B071-84A4-4DA0-AD00-0D8A04CAF696Q33640659-514BA873-A59B-4BF1-8002-7C37CA395C84Q33687575-7A5B444C-DD3F-46C3-8CDE-ECAF8871AA0CQ34149341-BDE137D3-945E-419C-825C-D945C001961CQ34721327-ABBA33C9-A3EA-4D90-8693-3428F9DED08EQ35564068-CBE79BC5-4C20-4761-9BFB-50D8F6E58489Q35600424-AE4A7099-0A0D-4607-9A08-A5B0D178CD38Q35799626-C1DD792F-CB55-4895-ABA7-E899616AE971Q36263417-033D7281-5F17-4C91-8DE9-F743A7C6AC24Q36996494-281876D5-5FEA-4736-9FC9-9785D7AD1E76Q37425080-0BABE36E-120A-460A-A5E0-AB77BA6FCA79Q37680631-D5B8A5DB-57D2-4636-B00E-D5F4C54F8A63Q37761324-0352B789-2BC3-4F38-B641-61231F241CFDQ38472616-F1DEF98C-9727-45AC-B80A-D20BAC1A84F1Q40670276-10A116FF-DB4A-4716-8C9F-50563DC53543Q41193444-B5E1317E-D9AF-4736-9695-A36A19213A2AQ41350765-9CBCB955-06D5-4E3B-AC4B-964187C5841BQ41986504-1B83CC8A-36E5-4B26-BDE2-BBFAFE684129Q42339328-DCE1D955-A658-4CE6-86CD-DDFB3A924038Q42584289-4E2FB889-4BCD-4E8B-AAC3-F01D3E6C0BA6Q42718266-E7BC696D-A78C-4C7E-9AFE-E8463B9359B7Q44326347-69CAA23B-91AD-40F2-9E2E-439E52AEDF81Q44409885-5D39A3AE-8214-4D44-A024-EDB75311F400Q44802295-88A870E0-CD08-4520-8EE9-71ED2740E1D0Q44958591-84D1556C-6B9A-4D21-821E-A5F15F19A3AEQ45065894-D0DE88F2-E43F-44B8-A9A5-A4AFDA4E376FQ45215952-1079051D-556B-4F5F-A2C4-2E329802F520Q46406762-6054BCB1-9B03-4330-BA3A-8D5210BC07E1Q46442489-82A4ACCD-FE66-463F-B175-F0A34AAC8224Q46509008-B28C4E25-BDB1-451E-AC7B-BB7FE01E2F53Q46723213-0A3266E3-424B-4BF7-8359-34BDD3938889Q46765278-C8A4BF90-316D-4B0D-B438-AB8589237D3DQ46893098-88607385-46A6-49F5-AB3D-F1BEB422E8C8Q50883662-57415D07-20C5-4554-A727-010263C593A2Q51345787-C01801CD-F6FB-4175-807F-6531895D7B5DQ51411509-2022D3F3-3059-4810-88AC-B6B906C3E95EQ51498458-9B1D7979-0AE5-4337-86AB-66BAE90CAF9D
P2860
Homocysteine and cardiovascular disease in diabetes mellitus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Homocysteine and cardiovascular disease in diabetes mellitus.
@ast
Homocysteine and cardiovascular disease in diabetes mellitus.
@en
Homocysteine and cardiovascular disease in diabetes mellitus.
@nl
type
label
Homocysteine and cardiovascular disease in diabetes mellitus.
@ast
Homocysteine and cardiovascular disease in diabetes mellitus.
@en
Homocysteine and cardiovascular disease in diabetes mellitus.
@nl
prefLabel
Homocysteine and cardiovascular disease in diabetes mellitus.
@ast
Homocysteine and cardiovascular disease in diabetes mellitus.
@en
Homocysteine and cardiovascular disease in diabetes mellitus.
@nl
P1433
P1476
Homocysteine and cardiovascular disease in diabetes mellitus.
@en
P2093
Audelin MC
Genest J Jr
P304
P356
10.1016/S0021-9150(01)00531-7
P577
2001-12-01T00:00:00Z